Works by Horinouchi, Hidehito

Results: 108
    1

    Comparison of Radiotherapy and Chemoradiotherapy for Locoregional Recurrence of Non-small-cell Lung Cancer Developing After Surgery.

    Published in:
    2017
    By:
    • Shinji Nakamichi;
    • Hidehito Horinouchi;
    • Tetsuhiko Asao;
    • Yasushi Goto;
    • Shintaro Kanda;
    • Yutaka Fujiwara;
    • Hiroshi Nokihara;
    • Noboru Yamamoto;
    • Yoshinori Ito;
    • Shun-ichi Watanabe;
    • Yuichiro Ohe;
    • Nakamichi, Shinji;
    • Horinouchi, Hidehito;
    • Asao, Tetsuhiko;
    • Goto, Yasushi;
    • Kanda, Shintaro;
    • Fujiwara, Yutaka;
    • Nokihara, Hiroshi;
    • Yamamoto, Noboru;
    • Ito, Yoshinori
    Publication type:
    journal article
    2

    Sequential Use of Anaplastic Lymphoma Kinase Inhibitors in Japanese Patients With ALK-Rearranged Non-Small-Cell Lung Cancer: A Retrospective Analysis.

    Published in:
    2017
    By:
    • Tetsuhiko Asao;
    • Yutaka Fujiwara;
    • Itahashi, Kota;
    • Shinsuke Kitahara;
    • Yasushi Goto;
    • Hidehito Horinouchi;
    • Shintaro Kanda;
    • Hiroshi Nokihara;
    • Noboru Yamamoto;
    • Kazuhisa Takahashi;
    • Yuichiro Ohe;
    • Asao, Tetsuhiko;
    • Fujiwara, Yutaka;
    • Kitahara, Shinsuke;
    • Goto, Yasushi;
    • Horinouchi, Hidehito;
    • Kanda, Shintaro;
    • Nokihara, Hiroshi;
    • Yamamoto, Noboru;
    • Takahashi, Kazuhisa
    Publication type:
    journal article
    3

    Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung Cancer.

    Published in:
    2017
    By:
    • Hitomi Sumiyoshi Okuma;
    • Hidehito Horinouchi;
    • Shinsuke Kitahara;
    • Tetsuhiko Asao;
    • Kuniko Sunami;
    • Yasushi Goto;
    • Shintaro Kanda;
    • Yutaka Fujiwara;
    • Hiroshi Nokihara;
    • Noboru Yamamoto;
    • Yuichiro Ohe;
    • Okuma, Hitomi Sumiyoshi;
    • Horinouchi, Hidehito;
    • Kitahara, Shinsuke;
    • Asao, Tetsuhiko;
    • Sunami, Kuniko;
    • Goto, Yasushi;
    • Kanda, Shintaro;
    • Fujiwara, Yutaka;
    • Nokihara, Hiroshi
    Publication type:
    journal article
    4
    5
    6

    Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance.

    Published in:
    NPJ Precision Oncology, 2020, v. 4, n. 1, p. 1, doi. 10.1038/s41698-020-0118-x
    By:
    • Schwartzberg, Lee S.;
    • Horinouchi, Hidehito;
    • Chan, David;
    • Chernilo, Sara;
    • Tsai, Michaela L.;
    • Isla, Dolores;
    • Escriu, Carles;
    • Bennett, John P.;
    • Clark-Langone, Kim;
    • Svedman, Christer;
    • Tomasini, Pascale;
    • Oncotype SEQ® Study Investigators and Program Team;
    • Alexander, Gregory;
    • Baehner, Frederick L.;
    • Bauer, Thomas;
    • Bergamaschi, Anna;
    • Crown, John;
    • Davison, Deborah;
    • Eberhard, David A.;
    • Gabrail, Nashat
    Publication type:
    Article
    7

    Top 20 EGFR+ NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating EGFR Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus Survey.

    Published in:
    Lung Cancer: Targets & Therapy, 2024, v. 15, p. 87, doi. 10.2147/LCTT.S463429
    By:
    • Ou, Sai-Hong Ignatius;
    • Le, Xiuning;
    • Nagasaka, Misako;
    • Reungwetwattana, Thanyanan;
    • Ahn, Myung-Ju;
    • Lim, Darren WT;
    • Santos, Edgardo S;
    • Shum, Elaine;
    • Lau, Sally CM;
    • Lee, Jii Bum;
    • Calles, Antonio;
    • Wu, Fengying;
    • Lopes, Gilberto;
    • Sriuranpong, Virote;
    • Tanizaki, Junko;
    • Horinouchi, Hidehito;
    • Garassino, Marina C;
    • Popat, Sanjay;
    • Besse, Benjamin;
    • Rosell, Rafael
    Publication type:
    Article
    8

    An ATR-PrimPol pathway confers tolerance to oncogenic KRAS-induced and heterochromatin-associated replication stress.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40578-2
    By:
    • Igarashi, Taichi;
    • Mazevet, Marianne;
    • Yasuhara, Takaaki;
    • Yano, Kimiyoshi;
    • Mochizuki, Akifumi;
    • Nishino, Makoto;
    • Yoshida, Tatsuya;
    • Yoshida, Yukihiro;
    • Takamatsu, Nobuhiko;
    • Yoshimi, Akihide;
    • Shiraishi, Kouya;
    • Horinouchi, Hidehito;
    • Kohno, Takashi;
    • Hamamoto, Ryuji;
    • Adachi, Jun;
    • Zou, Lee;
    • Shiotani, Bunsyo
    Publication type:
    Article
    9
    10

    Protocol summary of a randomized phase III study: comparing systemic therapy with and without debulking surgery (primary tumour resection) for clinical stage IVA (cT1-2bN0-1M1a) non-small cell lung cancer with radiologically undetermined pleural dissemination JCOG2103 (DEBULK-LUNG)

    Published in:
    Japanese Journal of Clinical Oncology, 2025, v. 55, n. 2, p. 176, doi. 10.1093/jjco/hyae143
    By:
    • Sekino, Yuta;
    • Hishida, Tomoyuki;
    • Yoshioka, Hiroshige;
    • Wakabayashi, Masashi;
    • Mitome, Noriko;
    • Shiono, Satoshi;
    • Kenmotsu, Hirotsugu;
    • Nosaki, Kaname;
    • Aokage, Keiju;
    • Horinouchi, Hidehito;
    • Fukuda, Haruhiko;
    • Ohe, Yuichiro;
    • Watanabe, Shun-ichi;
    • (JCOG), the Lung Cancer Surgical Study Group (LCSSG) and the Lung Cancer Study Group (LCSG) of the Japan Clinical Oncology Group
    Publication type:
    Article
    11
    12

    First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study.

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 4, p. 452, doi. 10.1093/jjco/hyad195
    By:
    • Imai, Hisao;
    • Kijima, Takashi;
    • Azuma, Koichi;
    • Kishi, Kazuma;
    • Saito, Haruhiro;
    • Yamaguchi, Teppei;
    • Tanizaki, Junko;
    • Yoneshima, Yasuto;
    • Fujita, Kohei;
    • Watanabe, Satoshi;
    • Kitazono, Satoru;
    • Fukuhara, Tatsuro;
    • Hataji, Osamu;
    • Toi, Yukihiro;
    • Mizutani, Hideaki;
    • Hamakawa, Yusuke;
    • Maemondo, Makoto;
    • Ohsugi, Tomoyuki;
    • Suzuki, Keisuke;
    • Horinouchi, Hidehito
    Publication type:
    Article
    13
    14

    Medical management of older patients with lung cancer.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 10, p. 1082, doi. 10.1093/jjco/hyac135
    By:
    • Zenke, Yoshitaka;
    • Hakozaki, Taiki;
    • Nakahara, Yoshiro;
    • Horinouchi, Hidehito;
    • Ohe, Yuichiro;
    • (JCOG), the Lung Cancer Study Group of the Japan Clinical Oncology Group
    Publication type:
    Article
    15

    Study protocol for JCOG1807C (DEEP OCEAN): a interventional prospective trial to evaluate the efficacy and safety of durvalumab before and after operation or durvalumab as maintenance therapy after chemoradiotherapy against superior sulcus non-small cell lung cancer

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 4, p. 383, doi. 10.1093/jjco/hyab208
    By:
    • Aokage, Keiju;
    • Tsuboi, Masahiro;
    • Zenke, Yoshitaka;
    • Horinouchi, Hidehito;
    • Nakamura, Naoki;
    • Ishikura, Satoshi;
    • Nishikawa, Hiroyoshi;
    • Kumagai, Shogo;
    • Koyama, Shohei;
    • Kanato, Keisuke;
    • Kataoka, Tomoko;
    • Wakabayashi, Masashi;
    • Fukutani, Miki;
    • Fukuda, Haruhiko;
    • Ohe, Yuichiro;
    • Watanabe, Shun-ichi;
    • Group, the Lung Cancer Surgical Study Group of the Japan Clinical Oncology
    Publication type:
    Article
    16

    Performance of Japanese patients in registrational studies.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 1, p. 53, doi. 10.1093/jjco/hyab171
    By:
    • Goto, Yasushi;
    • Arakawa, Sayaka;
    • Shirasawa, Masayuki;
    • Higashiyama, Ryoko;
    • Baba, Keisuke;
    • Masuda, Ken;
    • Shinno, Yuki;
    • Matsumoto, Yuji;
    • Okuma, Yusuke;
    • Yoshida, Tatsuya;
    • Horinouchi, Hidehito;
    • Yamamoto, Noboru;
    • Ohe, Yuichiro
    Publication type:
    Article
    17

    Corrigendum to: Feasibility of next-generation sequencing (Oncomine™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 7, p. 1183, doi. 10.1093/jjco/hyab092
    By:
    • Takeyasu, Yuki;
    • Yoshida, Tatsuya;
    • Motoi, Noriko;
    • Teishikata, Takashi;
    • Tanaka, Midori;
    • Matsumoto, Yuji;
    • Shinno, Yuki;
    • Okuma, Yusuke;
    • Goto, Yasushi;
    • Horinouchi, Hidehito;
    • Kakishima, Hiroki;
    • Tsuchida, Takaaki;
    • Yamamoto, Noboru;
    • Ohe, Yuichiro;
    • Yatabe, Yasushi
    Publication type:
    Article
    18

    Feasibility of next-generation sequencing (Oncomine™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 7, p. 1114, doi. 10.1093/jjco/hyab059
    By:
    • Takeyasu, Yuki;
    • Yoshida, Tatsuya;
    • Motoi, Noriko;
    • Teishikata, Takashi;
    • Tanaka, Midori;
    • Matsumoto, Yuji;
    • Shinno, Yuki;
    • Okuma, Yusuke;
    • Goto, Yasushi;
    • Horinouchi, Hidehito;
    • Kakishima, Hiroki;
    • Tsuchida, Takaaki;
    • Yamamoto, Noboru;
    • Ohe, Yuichiro;
    • Yatabe, Yasushi
    Publication type:
    Article
    19

    Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 1, p. 106, doi. 10.1093/jjco/hyaa157
    By:
    • Saka, Hideo;
    • Nishio, Makoto;
    • Hida, Toyoaki;
    • Nakagawa, Kazuhiko;
    • Sakai, Hiroshi;
    • Nogami, Naoyuki;
    • Atagi, Shinji;
    • Takahashi, Toshiaki;
    • Horinouchi, Hidehito;
    • Takenoyama, Mitsuhiro;
    • Katakami, Nobuyuki;
    • Tanaka, Hiroshi;
    • Takeda, Koji;
    • Satouchi, Miyako;
    • Isobe, Hiroshi;
    • Maemondo, Makoto;
    • Goto, Koichi;
    • Hirashima, Tomonori;
    • Minato, Koichi;
    • Yada, Nobumichi
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Correction: Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer.

    Published in:
    2023
    By:
    • Shirasawa, Masayuki;
    • Yoshida, Tatsuya;
    • Shiraishi, Kouya;
    • Goto, Naoko;
    • Yagishita, Shigehiro;
    • Imabayashi, Tatsuya;
    • Matsumoto, Yuji;
    • Masuda, Ken;
    • Shinno, Yuki;
    • Okuma, Yusuke;
    • Goto, Yasushi;
    • Horinouchi, Hidehito;
    • Yotsukura, Masaya;
    • Yoshida, Yukihiro;
    • Nakagawa, Kazuo;
    • Naoki, Katsuhiko;
    • Tsuchida, Takaaki;
    • Hamamoto, Ryuji;
    • Yamamoto, Noboru;
    • Motoi, Noriko
    Publication type:
    Correction Notice
    32

    Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer.

    Published in:
    British Journal of Cancer, 2023, v. 129, n. 12, p. 2003, doi. 10.1038/s41416-023-02427-3
    By:
    • Shirasawa, Masayuki;
    • Yoshida, Tatsuya;
    • Shiraishi, Kouya;
    • Goto, Naoko;
    • Yagishita, Shigehiro;
    • Imabayashi, Tatsuya;
    • Matsumoto, Yuji;
    • Masuda, Ken;
    • Shinno, Yuki;
    • Okuma, Yusuke;
    • Goto, Yasushi;
    • Horinouchi, Hidehito;
    • Yotsukura, Masaya;
    • Yoshida, Yukihiro;
    • Nakagawa, Kazuo;
    • Naoki, Katsuhiko;
    • Tsuchida, Takaaki;
    • Hamamoto, Ryuji;
    • Yamamoto, Noboru;
    • Motoi, Noriko
    Publication type:
    Article
    33
    34
    35
    36
    37

    Japan society of clinical oncology position paper on appropriate clinical use of molecular residual disease (MRD) testing.

    Published in:
    International Journal of Clinical Oncology, 2025, v. 30, n. 4, p. 605, doi. 10.1007/s10147-024-02683-0
    By:
    • Kobayashi, Shin;
    • Nakamura, Yoshiaki;
    • Hashimoto, Tadayoshi;
    • Bando, Hideaki;
    • Oki, Eiji;
    • Karasaki, Takahiro;
    • Horinouchi, Hidehito;
    • Ozaki, Yukinori;
    • Iwata, Hiroji;
    • Kato, Taigo;
    • Miyake, Hideaki;
    • Ohba, Akihiro;
    • Ikeda, Masafumi;
    • Chiyoda, Tatsuyuki;
    • Hasegawa, Kosei;
    • Fujisawa, Takao;
    • Matsuura, Kazuto;
    • Namikawa, Kenjiro;
    • Yajima, Shugo;
    • Yoshino, Takayuki
    Publication type:
    Article
    38

    Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1142, doi. 10.1007/s10147-024-02543-x
    By:
    • Nosaki, Kaname;
    • Yoh, Kiyotaka;
    • Toyozawa, Ryo;
    • Horinouchi, Hidehito;
    • Morise, Masahiro;
    • Ohashi, Kadoaki;
    • Murakami, Haruyasu;
    • Satouchi, Miyako;
    • Sakakibara-Konishi, Jun;
    • Yano, Seiji;
    • Okumura, Fumihiko;
    • Matsumoto, Shingo;
    • Shimokawa, Mototsugu;
    • Seto, Takashi;
    • Goto, Koichi
    Publication type:
    Article
    39
    40
    41

    Treatment patterns and clinical outcomes of resectable clinical stage III non‐small cell lung cancer in a Japanese real‐world setting: Surgery cohort analysis of the SOLUTION study.

    Published in:
    Thoracic Cancer, 2024, v. 15, n. 20, p. 1541, doi. 10.1111/1759-7714.15305
    By:
    • Tsuboi, Masahiro;
    • Murakami, Haruyasu;
    • Harada, Hideyuki;
    • Sobue, Tomotaka;
    • Kato, Tomohiro;
    • Atagi, Shinji;
    • Tokito, Takaaki;
    • Mio, Tadashi;
    • Adachi, Hirofumi;
    • Kozuki, Toshiyuki;
    • Sone, Takashi;
    • Seike, Masahiro;
    • Toyooka, Shinichi;
    • Kitagawa, Hiroshi;
    • Koto, Ryo;
    • Yamazaki, Satoshi;
    • Horinouchi, Hidehito
    Publication type:
    Article
    42

    Exploratory analysis to predict pneumonitis during durvalumab consolidation therapy for patients with locally advanced non‐small cell lung cancer from proteomic profiling of circulating extracellular vesicles.

    Published in:
    Thoracic Cancer, 2023, v. 14, n. 29, p. 2909, doi. 10.1111/1759-7714.15077
    By:
    • Torasawa, Masahiro;
    • Horinouchi, Hidehito;
    • Yagishita, Shigehiro;
    • Utsumi, Hirofumi;
    • Okuda, Keitaro;
    • Takekoshi, Daisuke;
    • Ito, Saburo;
    • Wakui, Hiroshi;
    • Murata, Saori;
    • Kaku, Sawako;
    • Okuma, Kae;
    • Matsumoto, Yuji;
    • Shinno, Yuki;
    • Okuma, Yusuke;
    • Yoshida, Tatsuya;
    • Goto, Yasushi;
    • Yamamoto, Noboru;
    • Araya, Jun;
    • Ohe, Yuichiro;
    • Fujita, Yu
    Publication type:
    Article
    43
    44
    45
    46
    47
    48

    Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non–small-cell Lung Cancer: SQUAT trial (WJOG 12119L).

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 6, p. 596, doi. 10.1016/j.cllc.2021.04.006
    By:
    • Hamada, Akira;
    • Soh, Junichi;
    • Hata, Akito;
    • Nakamatsu, Kiyoshi;
    • Shimokawa, Mototsugu;
    • Yatabe, Yasushi;
    • Oizumi, Hiroyuki;
    • Tsuboi, Masahiro;
    • Horinouchi, Hidehito;
    • Yoshino, Ichiro;
    • Tanahashi, Masayuki;
    • Toyooka, Shinichi;
    • Okada, Morihito;
    • Yokomise, Hiroyasu;
    • Yamashita, Motohiro;
    • Nishimura, Yasumasa;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko;
    • Mitsudomi, Tetsuya
    Publication type:
    Article
    49

    Activity and Immune Correlates of Programmed Death-1 Blockade Therapy in Patients With Advanced Large Cell Neuroendocrine Carcinoma.

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 4, p. 282, doi. 10.1016/j.cllc.2021.02.003
    By:
    • Shirasawa, Masayuki;
    • Yoshida, Tatsuya;
    • Takayanagi, Daisuke;
    • Shiraishi, Kouya;
    • Yagishita, Shigehiro;
    • Sekine, Katsutoshi;
    • Kanda, Shintaro;
    • Matsumoto, Yuji;
    • Masuda, Ken;
    • Shinno, Yuki;
    • Okuma, Yusuke;
    • Goto, Yasushi;
    • Horinouchi, Hidehito;
    • Hamada, Akinobu;
    • Kohno, Takashi;
    • Yamamoto, Noboru;
    • Watanabe, Shun-ichi;
    • Ohe, Yuichiro;
    • Motoi, Noriko
    Publication type:
    Article
    50